| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0161-6420(81)35069-6 |
| P698 | PubMed publication ID | 7015218 |
| P2093 | author name string | S I Brown | |
| B J Mondino | |||
| P2860 | cites work | Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19 | Q33650055 |
| Immunopathology of cicatricial pemphigoid: studies of complement deposition | Q40743585 | ||
| Autoimmune Phenomena of the External Eye | Q40959623 | ||
| Symblepharon in Sarcoidosis | Q43466957 | ||
| Benign mucous membrane pemphigoid. II. Cytology | Q43929357 | ||
| Circulating autoantibodies in ocular pemphigoid. | Q44227838 | ||
| Systemic disease associated with tear deficiencies | Q48695364 | ||
| HLA Antigens in Ocular Cicatricial Pemphigoid | Q66892610 | ||
| Results of keratoprosthesis | Q66919502 | ||
| The Acute Manifestations of Ocular Cicatricial Pemphigoid: Diagnosis and Treatment | Q66994631 | ||
| Induced ocular pseudopemphigoid | Q67487055 | ||
| Benign mucous membrane pemphigoid. 3. Biopsy | Q68940593 | ||
| Benign mucous membrane pemphigoid. 1. Secretion of mucus and tears | Q70018203 | ||
| Benign mucous membrane pemphigoid | Q70601259 | ||
| Ocular pemphigus | Q79247864 | ||
| P433 | issue | 2 | |
| P921 | main subject | cicatricial pemphigoid | Q627291 |
| P304 | page(s) | 95-100 | |
| P577 | publication date | 1981-02-01 | |
| P1433 | published in | Ophthalmology | Q7098109 |
| P1476 | title | Ocular cicatricial pemphigoid | |
| P478 | volume | 88 |
| Q89181350 | A case of antiepiligrin cicatricial pemphigoid with extensive cutaneous erosions mimicking pemphigus vulgaris |
| Q70555263 | Alcaligenes faecalis corneal ulcer in a patient with cicatricial pemphigoid |
| Q37277234 | Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring |
| Q71835304 | Anterior lamellar repositioning and grey line split for upper lid entropion in ocular cicatricial pemphigoid |
| Q37653167 | Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid |
| Q36237529 | Autoimmune bullous diseases: ocular manifestations and management |
| Q40827033 | B- and T-lymphocytes in Ocular Disease |
| Q42072540 | Blood group related antigens in ocular cicatricial pemphigoid |
| Q41432454 | Chemical injuries of the eye: current concepts in pathophysiology and therapy |
| Q40773560 | Chronic progressive conjunctival cicatrisation |
| Q68158346 | Cicatricial pemphigoid |
| Q37945609 | Cicatricial pemphigoid and erythema multiforme |
| Q72740427 | Cicatrizing conjunctivitis as a predominant manifestation of linear IgA bullous dermatosis |
| Q37354234 | Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid |
| Q72542182 | Conjunctival epithelial cell hypermitosis and goblet cell hyperplasia in atopic keratoconjunctivitis |
| Q37308498 | Cryotherapy for trichiasis in ocular cicatricial pemphigoid |
| Q37297613 | Dapsone therapy for the acute inflammatory phase of ocular pemphigoid |
| Q72357295 | Dapsone-induced neutropenia in patients treated for ocular cicatricial pemphigoid |
| Q37709776 | Defining the limits of normal conjunctival fornix anatomy in a healthy South Asian population |
| Q42521669 | Drug-induced cicatricial pemphigoid affecting the conjunctiva. Light and electron microscopic features |
| Q35304020 | Eosinophil granule proteins expressed in ocular cicatricial pemphigoid |
| Q35215156 | Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom |
| Q34436707 | Eye involvement in autoimmune blistering diseases |
| Q36264266 | Immunobullous Diseases With Ocular Involvement |
| Q69368774 | Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a T cell-mediated disease |
| Q70287560 | Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid |
| Q70249115 | Immunosuppressive therapy for progressive ocular cicatricial pemphigoid |
| Q36238300 | Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom |
| Q73211528 | Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid |
| Q37316226 | Inferior retractor plication surgery for lower lid entropion with trichiasis in ocular cicatricial pemphigoid |
| Q77144024 | Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction |
| Q77161223 | Mucous membrane pemphigoid |
| Q49833864 | Mucous membrane pemphigoid |
| Q35841567 | NGF Modulates trkANGFR/p75NTR in αSMA-Expressing Conjunctival Fibroblasts from Human Ocular Cicatricial Pemphigoid (OCP). |
| Q64095262 | Ocular Manifestations and Management of Autoimmune Bullous Diseases |
| Q64230980 | Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment |
| Q53091231 | Ocular and oral grading of mucous membrane pemphigoid. |
| Q99240901 | Ocular cicatricial pemphigoid (Review) |
| Q36168693 | Ocular cicatricial pemphigoid: manifestations and management |
| Q37264280 | Ocular mucous membrane pemphigoid: diagnosis and management strategies. |
| Q34756286 | Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid |
| Q37319447 | Progression of disease in ocular cicatricial pemphigoid |
| Q78022188 | Pure ocular cicatricial pemphigoid. A distinct immunopathologic subset of cicatricial pemphigoid |
| Q68097362 | Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid |
| Q57220852 | Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid |
| Q37311216 | Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid |
| Q92860765 | Role of immune cells in the ocular manifestations of pemphigoid diseases |
| Q24604349 | Severity score indexes for blistering diseases |
| Q37321480 | Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid |
| Q73138211 | Superior tarsal conjunctival bullae in cicatricial pemphigoid |
| Q71136941 | Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome |
| Q47147519 | Systemic and Topical Steroids in the Management of Oral Mucosal Lesions |
| Q39096598 | The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. |
| Q43842999 | The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid |
| Q42776930 | The evil curse of ocular pemphigoid |
| Q72798992 | The immunological features and pathophysiology of ocular cicatricial pemphigoid |
| Q71177433 | Treatment of severe dry eye |
| Q33708842 | Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity |
| Q34996874 | Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis |
| Q86836555 | [Human leukocyte antigen (HLA) system in ophthalmology] |
| Q80855750 | [Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis] |
Search more.